We could not find any results for:
Make sure your spelling is correct or try broadening your search.
HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...
HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...
HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...
HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting unique healthcare...
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.04 | -2.72108843537 | 1.47 | 1.7 | 1.16 | 50815 | 1.40584269 | CS |
4 | -1.4 | -49.4699646643 | 2.83 | 2.95 | 1.16 | 38723 | 1.91148388 | CS |
12 | -0.38 | -20.9944751381 | 1.81 | 3.25 | 1.16 | 53385 | 2.13776641 | CS |
26 | -1.57 | -52.3333333333 | 3 | 3.25 | 1.16 | 79796 | 2.25143989 | CS |
52 | -1.57 | -52.3333333333 | 3 | 3.25 | 1.16 | 79796 | 2.25143989 | CS |
156 | -1.57 | -52.3333333333 | 3 | 3.25 | 1.16 | 79796 | 2.25143989 | CS |
260 | -1.57 | -52.3333333333 | 3 | 3.25 | 1.16 | 79796 | 2.25143989 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions